|
|||
|
Multiple Sclerosis Info
|
Tuesday, February 5
by
multiplesclerosis
on Tue 05 Feb 2008 08:15 AM CST
The glycoprotein integrin is expressed on the surface of these cells and plays a critical part in their adhesion to the vascular endothelium and migration into the parenchyma. Tysabri (Natalizumab) is an integrin antagonist that reduced the development of brain lesions in more »
by
multiplesclerosis
on Tue 05 Feb 2008 08:02 AM CST
We used data from 13 adult neurology departments affiliated with the European Database for Multiple Sclerosis (EDMUS) network to identify a cohort of 394 patients who had multiple sclerosis with an onset at 16 years of age or younger and a more »
by
multiplesclerosis
on Tue 05 Feb 2008 07:35 AM CST
Among some patients with multiple sclerosis, fatigue appears to persist over time but appears to be related to mood symptoms of depression and not to disability, a trial more »
by
multiplesclerosis
on Tue 05 Feb 2008 12:00 AM CST
To examine prognosis and risk factors for progression to and from secondary-progressive multiple sclerosis (SPMS).
Methods:
Patients with definite relapsing-remitting MS (RRMS), onset before July 1988 more »
|
||